HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

被引：0
|
作者：
E Rakovitch
S Nofech-Mozes
W Hanna
S Narod
D Thiruchelvam
R Saskin
J Spayne
C Taylor
L Paszat
机构：
[1] University of Toronto,Department of Radiation Oncology University of Toronto
[2] Sunnybrook Health Sciences Centre,Department of Pathology
[3] University of Toronto,undefined
[4] 2075 Bayview Avenue,undefined
[5] Toronto M4N 3M5,undefined
[6] Canada,undefined
[7] Institute of Clinical Evaluative Sciences,undefined
[8] University of Toronto,undefined
[9] Women's College Hospital Research Institute,undefined
[10] University of Toronto,undefined
来源：
British Journal of Cancer | 2012年 / 106卷
关键词：
DCIS; biomarkers; recurrence; breast-conserving surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1160 / 1165
页数：5
相关论文
共 50 条
  • [31] MOLECULAR SUBTYPES OF DUCTAL CARCINOMA IN SITU IDENTIFIED BY EXPRESSION OF OESTROGEN AND PROGESTERONE RECEPTORS, HER2, AND KI67
    Chuthapisith, S.
    Chowchankit, I.
    Warnnissorn, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S17 - S18
  • [32] Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery
    Punglia, Rinaa S.
    Jiang, Wei
    Lipsitz, Stuart R.
    Hughes, Melissa E.
    Schnitt, Stuart J.
    Hassett, Michael J.
    Nekhlyudov, Larissa
    Achacoso, Ninah
    Edge, Stephen
    Javid, Sara H.
    Niland, Joyce C.
    Theriault, Richard L.
    Wong, Yu-Ning
    Habel, Laurel A.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (03) : 751 - 759
  • [33] HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma
    Liu, Tieju
    Sun, Baocun
    Zhao, Xiulan
    Gu, Qiang
    Dong, Xueyi
    Yao, Zhi
    Zhao, Nan
    Chi, Jiadong
    Liu, Ning
    Sun, Ran
    Ma, Yuemei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (01) : 116 - 122
  • [34] Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer
    Choi, Young Jin
    Shin, Young Duck
    Song, Young Jin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [35] Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery
    Rinaa S. Punglia
    Wei Jiang
    Stuart R. Lipsitz
    Melissa E. Hughes
    Stuart J. Schnitt
    Michael J. Hassett
    Larissa Nekhlyudov
    Ninah Achacoso
    Stephen Edge
    Sara H. Javid
    Joyce C. Niland
    Richard L. Theriault
    Yu-Ning Wong
    Laurel A. Habel
    Breast Cancer Research and Treatment, 2018, 167 : 751 - 759
  • [36] Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer
    Young Jin Choi
    Young Duck Shin
    Young Jin Song
    World Journal of Surgical Oncology, 14
  • [37] SALVAGE TREATMENT FOR RECURRENCE IN THE BREAST FOLLOWING BREAST-CONSERVING SURGERY AND DEFINITIVE IRRADIATION FOR DUCTAL CARCINOMA IN-SITU (INTRADUCTAL CARCINOMA) OF THE BREAST
    SOLIN, LJ
    FOURQUET, A
    MCCORMICK, B
    HAFFTY, B
    RECHT, A
    SCHULTZ, DJ
    BARRETT, W
    FOWBLE, B
    KUSKE, R
    TAYLOR, M
    MCNEESE, M
    AMALRIC, R
    KURTZ, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 146 - 146
  • [38] Histopathological Study of Gastric Adenocarcinoma with Special Reference to Expression of HER2/neu and Ki-67 Assessed by Immunohistochemistry
    Nisar, Saiqa
    Naskar, Sukla
    Biswas, Saumitra
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2024, 45 (05) : 422 - 429
  • [39] Expression of HER2/Neu in Ductal Carcinoma In Situ and Its Correlation with Clinical Pathological Factors
    Xu, J.
    Parker, K. M.
    LABORATORY INVESTIGATION, 2014, 94 : 89A - 89A
  • [40] Ductal carcinoma in situ (DCIS) of the breast in Israeli women treated by radiation therapy following breast-conserving surgery
    Jiveliouk, I.
    Corn, B.
    Inbar, M. J.
    Merimsky, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345